Scarban® C-Section is silicone scar therapy specially developed for C-Section aftercare. In order to reduce or prevent abnormal scarring after a caesarean section, we have introduced Scarban® C-Section. It is a specially pre-shaped silicone sheet which provides optimal and effective scar aftercare.
- Actively reduce scars 1
- Are effective on both new and old scar (hypertrophic / keloid) 1
- Are evidence based 1-4
Scar treatment after C-Section
Scarban® C-section is silicone scar therapy specially developed for C-Section aftercare.
- Elastic and self-adhesive
- 100% medical grade silicone
- UV protection (UPF 50)
- For all skin types
- Durable in use
- Safe and easy to use 1-4
Scarban® C-Section silicone sheets are supplied in a handy C-Section Recovery Kit, so that your patient can perform the scar treatment independently.
The Scarban® C-section Recovery Kit contains
- Scarban® C-Section silicone sheet*
- Mild silicone sheet cleaning and maintenance soap
- Information leaflet with instructions for use
The International Scar Management guidelines are clear 1-4
Silicone scar therapy is:
- The preferred therapy for both prevention and treatment of scars
- A proven, non-invasive option for scar therapy
- Evidence-based recommendations
- Safe and easy to use
1. Niessen, F. et al. Topical Silicone Sheet Application in the Treatment of Hypertrophic Scars and Keloids.
Journal of Clinical and Aesthetic Dermatology (2016) 9(10): 28-35
2. Monstrey, S. et al. Updated scar management practical guidelines: non-invasive and invasive measures.
Journal of Plastic, Reconstructive & Aesthetic Surgery (2014) 67: 1017-1025
3. Mustoe, T.A. et al. International Recommendations on Scar Management.
Journal of Plastic Reconstructive and Aesthetic Surgery (2002) 110(2): 560-571
4. Meaume, S. et al. Management of scars: updated practical guideline and use of silicones.
European Journal of Dermatology (2014) 24(4): 435-43
5. Gauglitz, G. et al. Hypertrophic Scarring and Keloids: Pathomechanisms and Current and Emerging Treatment Strategies.
Molecular Medicine (2011) Jan-Feb; 17(1-2)113-125